Study guide
Patient Identification, Clinical Screening & Pregnancy Protocols
NMTCB CT
Track your progress as you read
Finished sections get a check mark.
1 CT System Hardware & X-Ray Generation
X-Ray Tube Design and Focal Spots Tube Heat Loading, Bearings and Cooling Beam Filtration and Collimation Scanner Generations and Source/Detector Geometry Detector Technology & Data Acquisition Systems (DAS)
2 Gantry Mechanics & Ancillary Systems
Gantry Architecture, Clearance and Centering Slip Rings, Couch Motion and Load Safety Power Injector Hardware and Safety DICOM, Worklists and Image Archiving
3 Data Acquisition & Scanning Geometries
Axial vs. Helical Scanning & Pitch Mechanics Localizer/Scout Scans & Isocenter Alignment Beam Geometry, Slice Collimation & Data Sampling
4 Mathematical Reconstruction & Image Processing
Projection Data, Image Matrices and Voxel Sampling Filtered Back Projection and Reconstruction Kernels Iterative Reconstruction & AI-Powered Algorithms Hounsfield Unit Scale, Linear Attenuation & Windowing (WW/WL)
5 3D Visualization & Advanced Post-Processing
Multiplanar Reformation (MPR) & Curved Planar Reformation (CPR) Volume Rendering, Maximum/Minimum Intensity Projections & Virtual Endoscopy
6 Image Quality & Performance Metrics
Spatial Resolution, Modulation Transfer Function & Matrix Parameters MTF and Spatial-Resolution Testing Contrast Resolution, Quantum Noise & Temporal Resolution Interdependence of Image Quality Parameters & Radiation Dose
7 CT Artifacts Identification & Correction
Physics-Based Artifacts: Beam Hardening, Cupping & Partial Volume Averaging Equipment & Patient Artifacts: Ring, Motion, Metal & Windmill Effects
8 Quality Assurance & Routine Testing
Daily Quality Control: Water Calibration, Noise & Field Uniformity Periodic Quality Assurance: ACR Phantom Testing & Geometry Verification
9 Patient Communication, Screening & Preparation
Patient Identification, Clinical Screening & Pregnancy Protocols Informed Consent, Pre-Scan Fasting & Anxiety Management Patient Monitoring, Vital Signs Assessment & ECG Gating Setup
10 Infection Control & Medical Emergency Response
Infection Control, Aseptic Technique & Scanner Disinfection Medical Emergencies in the CT Suite: Vasovagal Reactions, Seizures & Code Protocols
11 Contrast Media Chemistry & Administration
Iodinated Contrast Properties: Osmolality, Viscosity & Molecular Structure Contrast Volume, Flow, Duration and Iodine Delivery Intravenous Access, Catheter Gauges & Power Injection Protocols Bolus Tracking, Test Bolus & Contrast Transit Dynamics
12 Non-Vascular Contrast & Adverse Reactions
Oral, Rectal and Enteral Contrast Intrathecal, Intra-articular and Cavitary Contrast Renal Impairment, CI-AKI Risk & Metformin Management Contrast Reactions: Categorization, Prophylaxis & Emergency Treatment
13 Neuroimaging & Head/Neck CT Protocols
Routine Brain and Trauma CT Technique Stroke, Hemorrhage and Targeted Skull-Base CT Facial Bones, Orbits & High-Resolution Temporal Bones Soft Tissue Neck & Paranasal Sinuses Protocols
14 Thoracic & Cardiovascular CT Protocols
Routine Chest CT: Pulmonary Parenchyma & Mediastinal Anatomy High-Resolution CT (HRCT) for Diffuse Interstitial Lung Disease Pulmonary Embolism & Cardiac CT Protocols
15 Abdominal & Pelvic CT Protocols
Multiphase Liver, Pancreas & Renal CT Protocols Gastrointestinal CT: Enterography, Colonography & Acute Abdomen Pelvic Cross-Sectional Anatomy & Gynecologic/Urologic Pathology
16 Musculoskeletal, Vascular & Interventional CT
Cervical, Thoracic and Lumbosacral Spine CT Extremity, Joint and Orthopedic Hardware CT CT Angiography (CTA): Carotid, Aortic & Peripheral Runoff Protocols CT-Guided Interventions: Biopsy, Abscess Drainage & Procedural Safety
17 Hybrid PET/CT and SPECT/CT Procedures
PET/CT Anatomy, Physiology and Attenuation Correction SPECT/CT Anatomy, Physiology and Attenuation Correction
18 Radiation Biology & Dose Descriptors
Radiation Physics, Cellular Interactions & Biological Risk Models Tissue Reactions, Stochastic Risk and Justification CTDI Measurement and Phantom References CTDI Weighting, Pitch and DLP Calculations Size-Specific Dose Estimates Effective-Dose Estimates and Diagnostic Reference Levels
19 Radiation Protection & Dose Optimization
Technical Dose Reduction: Tube Current Modulation & Pediatric ALARA Pediatric, Body-Habitus and Pregnancy Optimization Personnel Protection, Distance and Shielding Jurisdiction, Dose Limits and Personnel Monitoring
Patient Identification, Clinical Screening & Pregnancy Protocols
Key Takeaways Explain This Topic AI
Verify the patient and ordered examination before acquisition.
Pregnancy assessment follows the clinical situation and institutional process.
Contrast risks require individualized review rather than one automatic prohibition.
Last updated: October 2026
Confirm the patient, order and clinical question
Use the required independent identifiers to match the patient to the order and record. A room number or physical location is not an adequate identifier. Review the requested examination, indication, anatomical site, contrast route and relevant clinical information. If an order and the clinical question conflict—for example, an unenhanced routine scan requested for a vascular emergency—obtain clarification through the responsible clinician before proceeding.
Screening is not simply a checklist of reasons to refuse imaging. It identifies circumstances that change preparation, technique, monitoring or the benefit-risk decision. Record the information and communicate meaningful findings so that the authorized team can choose an appropriate plan. A technically successful scan of the wrong patient or wrong region has failed the basic identity and indication task.
Prior reactions and current medications
Ask what happened during a previous contrast administration, which class of agent was used, how severe the event was and what treatment was needed. A prior allergic-like reaction to the same class is a meaningful risk factor; nonspecific warmth or isolated nausea may represent a physiologic effect instead. Clarify the history rather than recording every unpleasant sensation as anaphylaxis.
Seafood, shellfish or povidone-iodine allergy does not create a special “iodine allergy” that uniquely predicts iodinated contrast reactions. Asthma and unrelated allergies may increase risk, but do not alone require routine premedication. A prior severe same-class reaction needs an individualized plan, potentially considering another examination, an agent change and appropriate preparation. No test dose or premedication guarantees that a reaction will not occur.
Review metformin, anticoagulants, cardiac medications and other drugs relevant to the examination. Metformin management depends on renal function, AKI and route-specific concerns; it is not automatically held for every IV contrast CT. Cardiac CTA medications and procedures requiring puncture have additional medication checks under their respective protocols. Do not independently discontinue therapy from a generalized study-guide table.
Renal assessment and laboratory interpretation
Use the department's risk-based process to determine whether a renal measurement is needed and whether it is recent enough for the patient's condition. Estimated glomerular filtration rate (eGFR) helps assess stable kidney function, but it is less reliable when creatinine is changing during acute kidney injury (AKI). Ask about recent illness, renal disease and other relevant history rather than treating one old laboratory result as permanent clearance.
Stable eGFR at least 30 mL/min/1.73 m² without AKI does not automatically require prophylactic IV hydration under ACR guidance. AKI or eGFR below 30 warrants the responsible team's benefit-risk assessment and prevention plan when appropriate. There is no universal creatinine value that independently forbids all necessary contrast imaging. Document the reviewed result and decision, including any instruction to modify the plan.
Pregnancy screening and justification
Assess pregnancy possibility according to the examination's radiation risk and institutional policy. Menstrual history, patient-reported possibility and testing may be relevant. Do not invent one mandatory age interval or assume that a scan within ten days of menstruation eliminates pregnancy. A negative test can be limited by timing and should be interpreted with the clinical context.
If pregnancy is known or suspected, notify the responsible clinician so that the indication, alternatives, scan range and technique can be assessed. Necessary CT is not automatically forbidden. Fetal exposure depends strongly on whether the fetus is in the direct beam and on the actual acquisition. A head examination differs from an abdominopelvic examination; one fixed fetal-dose number cannot describe every scanner and protocol.
Avoid unnecessary phases and repeats, preserve the required information and use physicist assistance for a dose estimate when needed. Radiation-risk counseling should use the actual circumstances and avoid claiming either zero risk or inevitable harm. The responsible clinical team makes the justification decision and documents it appropriately.
Iodinated contrast in pregnancy and breastfeeding
Iodinated contrast crosses the placenta. Use it when the clinical benefit justifies administration rather than withholding it solely because pregnancy is present. Follow current guidance and the patient's clinical pathway regarding neonatal care; do not invent a universal additional test requirement from a technical guide.
After maternal IV iodinated contrast, less than 1% of the maternal dose enters breast milk and less than 1% of that ingested amount is absorbed by the infant. Thus the estimated infant systemic exposure is less than 0.01% of the maternal administered dose, not 0.01 as a fraction of the full dose. ACR guidance supports continued breastfeeding. Discuss a parent's preference with the responsible clinician instead of instructing every patient to discard milk for 24–48 hours.
Practical contraindications and positioning limitations
Assess whether the patient can lie safely, maintain the necessary airway, tolerate the scan duration and follow instructions. Check body habitus against the couch's rated load and gantry clearance. Preserve trauma immobilization and relevant lines, drains or oxygen. A limitation may require a modified position, shorter protocol, additional support or another imaging plan.
- Screening finding Needed decision
- Unclear prior reaction Clarify agent, symptoms, severity and treatment
- Changing renal function Assess AKI rather than relying only on eGFR
- Possible pregnancy Apply risk-based policy and clinical justification
- Unsafe positioning or equipment fit Obtain an appropriate supported imaging plan
- Close the loop in the record
Record clinically relevant findings, laboratory information, notifications and the final authorized plan. Protect confidentiality when discussing sensitive history; do not announce pregnancy possibility or a diagnosis in a public waiting area. Screening is complete when identified issues have an accountable decision and the acquisition matches that decision, not merely when every field has been clicked.
Reference: ACR contrast manual , FDA radiation-risk guidance .